...chronic HIV-1 infection on highly active anti-retroviral therapy (HAART) showed that intramuscular prime-boost vaccination with THV01-1...
...received 5x10 6, 5x10 7 and 5x10 8 transducing units doses of THV01-1 and THV01-2. THV01-1...
...in Vancouver. Theravectys S.A. , Paris, France Product: THV01-1 Business: Infectious Molecular target: NA Description: Therapeutic vaccine against HIV...

...chronic HIV-1 infection on highly active anti-retroviral therapy (HAART) showed that intramuscular prime-boost vaccination with THV01-1...
...IFN) gamma , IFN alpha and IL-2. Furthermore, 93% of patients who received the prime-boost THV01-1/THV01-2...
...received 5x10 6, 5x10 7 and 5x10 8 transducing units doses of THV01-1 and THV01-2. THV01-1...

...manufacturing process to Henogen and had no knowledge of Theravectys’ processes. Theravectys’ THV01-1 -- a therapeutic vaccine against HIV...

...trial evaluating 3 dose levels of intramuscular THV01-1 followed by THV01-2 given 8 weeks apart. THV01-1...
...THV01-2 are lentiviral vectors coding for the same anti-HIV antigen but that have different envelopes. THV01-1...
...Jersey serotype. Theravectys S.A. , Paris, France Product: THV01-1 Business: Infectious Molecular target: NA Description: Therapeutic vaccine against HIV...

...trial evaluating 3 dose levels of intramuscular THV01-1 followed by THV01-2 given 8 weeks apart. THV01-1...
...THV01-2 are lentiviral vectors coding for the same anti-HIV antigen but that have different envelopes. THV01-1...
...Jersey serotype. Theravectys S.A. , Paris, France Product: THV01-2 Business: Infectious Molecular target: NA Description: Therapeutic vaccine against HIV...

...investors, including Financiere IDAT and FGP Capital, also participated along with new private investors. Theravectys' THV01-1...

...dose levels of intramuscular THV01-1 followed by THV01-2 given 8 weeks apart in 36 patients. THV01-1...
...THV01-2 are lentiviral vectors coding for the same anti-HIV antigen but that have different envelopes. THV01-1...
...Jersey serotype. Theravectys S.A.S. , Paris, France Product: THV01-1 Business: Infectious Molecular target: NA Description: Therapeutic vaccine against HIV...

...dose levels of intramuscular THV01-1 followed by THV01-2 given 8 weeks apart in 36 patients. THV01-1...
...THV01-2 are lentiviral vectors coding for the same anti-HIV antigen but that have different envelopes. THV01-1...
...Jersey serotype. Theravectys S.A.S. , Paris, France Product: THV01-2 Business: Infectious Molecular target: NA Description: Therapeutic vaccine against HIV...